Nutex Health Inc. (NASDAQ:NUTX – Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 84,600 shares, a growth of 40.3% from the March 15th total of 60,300 shares. Based on an average daily volume of 56,800 shares, the days-to-cover ratio is currently 1.5 days. Currently, 2.6% of the shares of the company are sold short.
Insiders Place Their Bets
In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 8th. The stock was acquired at an average price of $81.81 per share, with a total value of $81,810.00. Following the transaction, the chief financial officer now owns 4,888 shares of the company’s stock, valued at approximately $399,887.28. This trade represents a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 38.52% of the company’s stock.
Institutional Trading of Nutex Health
Large investors have recently bought and sold shares of the stock. State Street Corp bought a new position in shares of Nutex Health during the third quarter valued at $225,000. Beaird Harris Wealth Management LLC acquired a new stake in shares of Nutex Health during the 3rd quarter worth about $69,000. Drive Wealth Management LLC bought a new position in Nutex Health during the 4th quarter valued at about $1,122,000. Baader Bank Aktiengesellschaft acquired a new position in Nutex Health in the fourth quarter valued at about $206,000. Finally, Legato Capital Management LLC grew its stake in Nutex Health by 26.8% during the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company’s stock worth $1,004,000 after buying an additional 6,697 shares during the last quarter. 5.32% of the stock is currently owned by institutional investors.
Nutex Health Stock Up 8.8 %
Nutex Health (NASDAQ:NUTX – Get Free Report) last released its quarterly earnings data on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The company had revenue of $81.30 million for the quarter, compared to the consensus estimate of $81.13 million.
Wall Street Analysts Forecast Growth
Separately, Maxim Group boosted their target price on shares of Nutex Health from $75.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, April 8th.
Get Our Latest Research Report on Nutex Health
Nutex Health Company Profile
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Articles
- Five stocks we like better than Nutex Health
- What is a penny stock? A comprehensive guide
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- Using the MarketBeat Dividend Tax Calculator
- AppLovin: Can Record Profits Overcome Market Skepticism?
- Trading Halts Explained
- MarketBeat Week in Review – 04/14 – 04/18
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.